ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,646,063 | +5.8% | 318,514 | +19.7% | 0.03% | +7.7% |
| Q2 2023 | $8,173,873 | +59.3% | 265,990 | +86.8% | 0.03% | +23.8% |
| Q1 2023 | $5,131,537 | +1.8% | 142,424 | +11.6% | 0.02% | -8.7% |
| Q4 2022 | $5,041,668 | +4.5% | 127,621 | +6.3% | 0.02% | -4.2% |
| Q3 2022 | $4,823,000 | -7.5% | 120,009 | -3.2% | 0.02% | 0.0% |
| Q2 2022 | $5,216,000 | +8.0% | 123,988 | 0.0% | 0.02% | +26.3% |
| Q1 2022 | $4,830,000 | +2.6% | 123,988 | +5.0% | 0.02% | +5.6% |
| Q4 2021 | $4,707,000 | +10.3% | 118,084 | 0.0% | 0.02% | +5.9% |
| Q3 2021 | $4,266,000 | -11.9% | 118,084 | 0.0% | 0.02% | -15.0% |
| Q2 2021 | $4,841,000 | -6.0% | 118,084 | 0.0% | 0.02% | -16.7% |
| Q1 2021 | $5,151,000 | – | 118,084 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |